Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1

Carcinogenesis

Volumn 33, Issue 8, 2012, Pages 1468-1478

  Shi, Yin ^a,b,c   Tao, Yong Guang ^a,b,c   Jiang, Yiqun ^a,b,c   Xu, Yang ^a,d   Yan, Bin ^a,b,c   Chen, Xue ^a,b,c   Xiao, Lanbo ^a,b,c   Cao, Ya ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; LATENT MEMBRANE PROTEIN 1; NUCLEAR RECEPTOR COACTIVATOR 2;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; DNA PRIMERS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENE PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84865346500     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs171     Document Type: Article

References (44)

1. Dittmann, K. et al. (2008) Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol. Cancer, 7, 69-78.
2. Wang, S.C. et al. (2006) Tyrosine phosphorylation controls PCNA function through protein stability. Nat. Cell Biol., 8, 1359-1368.
3. Linggi, B. et al. (2006) ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol., 16, 649-656.
4. Kim, J. et al. (2007) The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res., 67, 9229-9237.
5. Wanner, G. et al. (2008) Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother. Oncol., 86, 383-390.
6. Li, C. et al. (2009) Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene, 28, 3801-3813.
7. Tao, Y. et al. (2005) Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Exp. Cell Res., 303, 240-251.
8. Wang, Y.N. et al. (2010) Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene, 29, 3997-4006.
9. Lo, H.W. et al. (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell, 7, 575-589.
10. Hanada, N. et al. (2006) Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol. Carcinog., 45, 10-17.
11. Hung, L.Y. et al. (2008) Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res., 36, 4337-4351.
12. Lo, H.W. et al. (2010) Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol. Cancer Res., 8, 232-245.
13. Rosenfeld, M.G. et al. (2006) Sensors and signals: a coactivator/corepressor/ epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev., 20, 1405-1428.
14. Xu, J. et al. (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol., 17, 1681-1692.
15. Fujimoto, N. et al. (2001) Different expression of androgen receptor coactivators in human prostate. Urology, 58, 289-294.
16. He, Y. et al. (2010) STAMP alters the growth of transformed and ovarian cancer cells. BMC Cancer, 10, 128-139.
17. Iwase, H. (2003) Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer, 10, 89-96.
18. Gregory, C.W. et al. (2004) Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J. Biol. Chem., 279, 7119-7130.
19. Zheng, H. et al. (2007) Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol. Immunol., 4, 185-196.
20. Lin, S.Y. et al. (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol., 3, 802-808.
21. Deng, L. et al. (2003) Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res., 13, 187-194.
22. Murphy, L.C. et al. (2000) Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Res., 60, 6266-6271.
23. Anzick, S.L. et al. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968.
24. Gregory, C.W. et al. (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res., 61, 4315-4319.
25. Grivas, P.D. et al. (2009) Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int. J. Colorectal Dis., 24, 613-622.
26. Cavarretta, I.T. et al. (2002) Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation. Mol. Endocrinol., 16, 253-270.
27. Arteaga, C.L. (2003) EGF receptor as a therapeutic target: patient selection and mechanisms of resistance to receptor-targeted drugs. J. Clin. Oncol., 21, 289-291.
28. Lo, H.W. et al. (2006) Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br. J. Cancer, 94, 184-188.
29. Lo, H.W. et al. (2005) Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res., 65, 338-348.
30. Carmena, M. et al. (2003) The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol., 4, 842-854.
31. Raper, S.E. et al. (1987) Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology, 92, 1243-1250.
32. Grasl-Kraupp, B. et al. (2002) A novel mechanism for mitogenic signaling via pro-transforming growth factor alpha within hepatocyte nuclei. Hepatology, 35, 1372-1380.
33. Tao, Y. et al. (2002) [EB virus encoded latent membrane protein 1 modulates the phosphorylation of epidermal growth factor receptor in nasopharyngeal carcinoma cell line]. Zhonghua Zhong Liu Za Zhi, 24, 226-229.
34. Miller, W.E. et al. (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol., 69, 4390-4398.
35. Huo, L. et al. (2010) RNA helicase A is a DNA-binding partner for EGFRmediated transcriptional activation in the nucleus. Proc. Natl Acad. Sci. USA, 107, 16125-16130.
36. Kitagawa, H. et al. (2002) Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol. Cell Biol., 22, 3698-3706.
37. Hu, S. et al. (2009) Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell, 139, 610-622.
38. Chinenov, Y. et al. (2008) GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. Proc. Natl Acad. Sci. USA, 105, 20185-20190.
39. Deguchi, K. et al. (2003) MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell, 3, 259-271.
40. Yang, X.J. et al. (2007) MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene, 26, 5408-5419.
41. Dittmann, K. et al. (2005) Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem., 280, 31182-31189.
42. Huang, W.C. et al. (2011) Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancerresistant protein expression in gefitinib-resistant cells. J. Biol. Chem., 286, 20558-20568.
43. Liccardi, G. et al. (2011) EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res., 71, 1103-1114.
44. Dittmann, K. et al. (2011) Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiother. Oncol., 99, 317-322.